NCT05367908已完成不适用
Discoveries - Different Immunization Boosters for Covid-19: Effect on Response in Antibodies
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,501
- 试验地点
- 1
- 主要终点
- Change in Antibody Levels Since Receiving a COVID-19 Booster Vaccine at 0, 1, and 2 Months Post Enrollment
研究概览
简要总结
This study will investigate antibody levels with respect to time since receiving a COVID-19 booster shot. The study will be decentralized, where participants can complete all study tasks at home. Self-reported participant information will be collected via surveys conducted at intake and monthly throughout the study. Participants will also perform monthly at-home capillary blood draws via YourBio devices that will be mailed to the designated laboratory for sample processing and antibody testing.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Lives in the continental United States.
- •Has been vaccinated against COVID-19 with a U.S.-authorized vaccine (that is, received the single shot J&J vaccine or both shots in the Pfizer or Moderna series).
- •Has received a COVID-19 booster between September 2021 and screening.
- •Is willing and able to submit vaccination card photo(s).
- •Is willing and able to self-collect capillary blood 3 times during the study period via an at-home whole-blood collection device (that is, the YourBio TAP II Device).
排除标准
- •Has been diagnosed with significant cognitive impairment or dementia.
- •Has received more than one COVID-19 vaccine booster at screening.
- •Is currently participating in a COVID-19 vaccine clinical trial.
- •Is currently receiving chemotherapy or has received chemotherapy in the past 6 months.
- •Is currently taking steroids, such as prednisone, for any condition.
- •Has been diagnosed with or is taking medications for rheumatoid arthritis (RA), lupus or multiple sclerosis (MS).
- •Has received an organ transplant
- •Is currently undergoing dialysis of any kind (for example, hemodialysis or chronic ambulatory dialysis) for kidney disease.
结局指标
主要结局
Change in Antibody Levels Since Receiving a COVID-19 Booster Vaccine at 0, 1, and 2 Months Post Enrollment
时间窗: Baseline (Month 0), Month 1, and Month 2
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Baby Vaccine Study (Sched3)Infectious DiseasesNCT02482636University of Oxford189
Unknown
不适用
Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de AburraCOVID-19NCT05172167Universidad de Antioquia200
终止
不适用
Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster VaccinesAnti-SARS-CoV-2 Antibody ResponseNCT05142540Medical University of Graz140
已完成
3 期
Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary VaccinationInfections, MeningococcalNCT01777308GlaxoSmithKline156
Unknown
不适用
Immunity After COVID-19 VaccinationImmunity to COVID-19NCT04883164Plexision300